Literature DB >> 29589976

The transluminal attenuation gradient in coronary CT angiography for the detection of hemodynamically significant disease: can all arteries be treated equally?

Shinichiro Fujimoto1, Andreas A Giannopoulos2,3, Kanako K Kumamaru2,4, Rie Matsumori1, Anji Tang2, Etsuro Kato1, Yuko Kawaguchi1, Kazuhisa Takamura1, Katsumi Miyauchi1, Hiroyuki Daida1, Frank J Rybicki5,6, Dimitris Mitsouras2,5,7.   

Abstract

OBJECTIVE: Results of the use of the transluminal attenuation gradient (TAG) at coronary CT angiography (CCTA) to predict hemodynamically significant disease vary widely. This study tested whether diagnostic performance of TAG to predict fractional flow reserve (FFR) ≤ 0.8 is improved when applied separately to subsets of coronary arteries that carry similar physiological flow.
METHODS: 28 patients with 64 × 0.5 mm CCTA and invasive FFR in ≥1 major coronary artery were retrospectively evaluated. Two readers assessed TAG in each artery. The receiver operating characteristic (ROC) area under the curve (AUC) was used to assess the diagnostic performance of TAG to detect hemodynamically significant disease following a clinical use rule [negative: FFR > 0.8 or ≤ 25% diameter stenosis (DS) at invasive catheter angiography; positive: FFR ≤ 0.8 or ≥ 90% DS at invasive catheter angiography]. ROC AUC was compared for all arteries pooled together, vs separately for arteries carrying similar physiological flow (Group 1: all left anterior descending plus right-dominant left circumflex; Group 2: right-dominant RCA plus left/co-dominant left circumflex).
RESULTS: Of the 84 arteries, 30 had FFR measurements, 30 had ≤25% DS and 13 had ≥90% DS. 11 arteries with 26-89% DS and no FFR measurement were excluded. TAG interobserver reproducibility was excellent (Pearson r = 0.954, Bland-Altman bias: 0.224 Hounsfield unit cm-1). ROC AUC to detect hemodynamically significant disease was higher when considering arteries separately (Group 1 AUC = 0.841, p = 0.039; Group 2 AUC = 0.840, p = 0.188), than when pooling all arteries together (AUC = 0.661).
CONCLUSION: Incorporating information on the physiology of coronary flow via the particular vessel interrogated and coronary dominance may improve the accuracy of TAG, a simple measurement that can be quickly performed at the time of CCTA interpretation to detect hemodynamically significant stenosis in individual coronary arteries. Advances in knowledge: The interpretation of TAG may benefit by incorporating information regarding which coronary artery is being interrogated.

Entities:  

Mesh:

Year:  2018        PMID: 29589976      PMCID: PMC6221776          DOI: 10.1259/bjr.20180043

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  20 in total

Review 1.  Intravenous contrast medium administration and scan timing at CT: considerations and approaches.

Authors:  Kyongtae T Bae
Journal:  Radiology       Date:  2010-07       Impact factor: 11.105

Review 2.  Does coronary flow trump coronary anatomy?

Authors:  K Lance Gould
Journal:  JACC Cardiovasc Imaging       Date:  2009-08

3.  Diagnostic accuracy and discrimination of ischemia by fractional flow reserve CT using a clinical use rule: results from the Determination of Fractional Flow Reserve by Anatomic Computed Tomographic Angiography study.

Authors:  Angus G Thompson; Rekha Raju; Philipp Blanke; Tae-Hyun Yang; Giovanni Battista John Mancini; Matthew J Budoff; Bjarne L Norgaard; James K Min; Jonathon A Leipsic
Journal:  J Cardiovasc Comput Tomogr       Date:  2015-01-21

4.  Noninvasive diagnosis of ischemia-causing coronary stenosis using CT angiography: diagnostic value of transluminal attenuation gradient and fractional flow reserve computed from coronary CT angiography compared to invasively measured fractional flow reserve.

Authors:  Yeonyee E Yoon; Jin-Ho Choi; Ji-Hyun Kim; Kyung-Woo Park; Joon-Hyung Doh; Yong-Jin Kim; Bon-Kwon Koo; James K Min; Andrejs Erglis; Hyeon-Cheol Gwon; Yeon Hyeon Choe; Dong-Ju Choi; Hyo-Soo Kim; Byung-Hee Oh; Young-Bae Park
Journal:  JACC Cardiovasc Imaging       Date:  2012-11

5.  Diagnostic performance of intracoronary gradient-based methods by coronary computed tomography angiography for the evaluation of physiologically significant coronary artery stenoses: a validation study with fractional flow reserve.

Authors:  Jin-Ho Choi; Bon-Kwon Koo; Yeonyee E Yoon; James K Min; Young-Bin Song; Joo-Yong Hahn; Seung-Hyuk Choi; Hyeon-Cheol Gwon; Yeon Hyeon Choe
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2012-07-15       Impact factor: 6.875

6.  Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation.

Authors:  Pim A L Tonino; William F Fearon; Bernard De Bruyne; Keith G Oldroyd; Massoud A Leesar; Peter N Ver Lee; Philip A Maccarthy; Marcel Van't Veer; Nico H J Pijls
Journal:  J Am Coll Cardiol       Date:  2010-06-22       Impact factor: 24.094

7.  Transluminal attenuation gradient in coronary computed tomography angiography is a novel noninvasive approach to the identification of functionally significant coronary artery stenosis: a comparison with fractional flow reserve.

Authors:  Dennis T L Wong; Brian S Ko; James D Cameron; Nitesh Nerlekar; Michael C H Leung; Yuvaraj Malaiapan; Marcus Crossett; Darryl P Leong; Stephen G Worthley; John Troupis; Ian T Meredith; Sujith K Seneviratne
Journal:  J Am Coll Cardiol       Date:  2013-02-13       Impact factor: 24.094

8.  Can differences in corrected coronary opacification measured with computed tomography predict resting coronary artery flow?

Authors:  Benjamin J W Chow; Malek Kass; Owen Gagné; Li Chen; Yeung Yam; Alexander Dick; George A Wells
Journal:  J Am Coll Cardiol       Date:  2011-03-15       Impact factor: 24.094

9.  Diagnostic accuracy of fractional flow reserve from anatomic CT angiography.

Authors:  James K Min; Jonathon Leipsic; Michael J Pencina; Daniel S Berman; Bon-Kwon Koo; Carlos van Mieghem; Andrejs Erglis; Fay Y Lin; Allison M Dunning; Patricia Apruzzese; Matthew J Budoff; Jason H Cole; Farouc A Jaffer; Martin B Leon; Jennifer Malpeso; G B John Mancini; Seung-Jung Park; Robert S Schwartz; Leslee J Shaw; Laura Mauri
Journal:  JAMA       Date:  2012-09-26       Impact factor: 56.272

10.  Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: the NXT trial (Analysis of Coronary Blood Flow Using CT Angiography: Next Steps).

Authors:  Bjarne L Nørgaard; Jonathon Leipsic; Sara Gaur; Sujith Seneviratne; Brian S Ko; Hiroshi Ito; Jesper M Jensen; Laura Mauri; Bernard De Bruyne; Hiram Bezerra; Kazuhiro Osawa; Mohamed Marwan; Christoph Naber; Andrejs Erglis; Seung-Jung Park; Evald H Christiansen; Anne Kaltoft; Jens F Lassen; Hans Erik Bøtker; Stephan Achenbach
Journal:  J Am Coll Cardiol       Date:  2014-01-30       Impact factor: 24.094

View more
  4 in total

1.  Diagnostic value of hepatic artery perfusion fraction combined with TGF-β in patients with hepatocellular carcinoma.

Authors:  Qingxu Liu; Yan Gao; Yongxue Wang; Jiexin Du; Qiang Yin; Kewei Shi
Journal:  Oncol Lett       Date:  2019-04-08       Impact factor: 2.967

2.  Assessment of coronary spasms with transluminal attenuation gradient in coronary computed tomography angiography.

Authors:  Jae Yang Park; Eun-Ju Kang; Moo Hyun Kim; Hwan Seok Yong; Seung-Woon Rha
Journal:  PLoS One       Date:  2022-07-08       Impact factor: 3.752

3.  Shape and Enhancement Analysis as a Useful Tool for the Presentation of Blood Hemodynamic Properties in the Area of Aortic Dissection.

Authors:  Andrzej Polanczyk; Aleksandra Piechota-Polanczyk; Ludomir Stefanczyk; Michal Strzelecki
Journal:  J Clin Med       Date:  2020-05-02       Impact factor: 4.241

4.  The Effects of a Vasodilator on Transluminal Attenuation Gradient at Coronary Computed Tomography Angiography.

Authors:  Moon Sung Kim; Eun Ju Kang; Hyun Jin Kim; Moo Hyun Kim; Ki Nam Lee
Journal:  Korean J Radiol       Date:  2020-08-04       Impact factor: 3.500

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.